[New developments in therapy of non-Hodgkin lymphomas with monoclonal antibodies].
Buske
C
C
Medizinische Klinik III, Klinikum Grosshadern, Ludwig-Maximilians-Universität München. chrisb@terryfox.ubc.ca
Feuring-Buske
M
M
Unterhalt
M
M
Hiddemann
W
W
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D000918:Antibody Specificity / Q000276:immunology; D002986:Clinical Trials as Topic; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use; D016393:Lymphoma, B-Cell / Q000276:immunology / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology / Q000628:therapy*; D016499:Radioimmunotherapy; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D000922:Immunotoxins
Neue Entwicklungen in der Therapie von Non-Hodgkin Lymphomen mit monoklonalen Antikörpern.